Cargando…
Famotidine: A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292911/ https://www.ncbi.nlm.nih.gov/pubmed/37399740 http://dx.doi.org/10.1016/j.jpsychores.2023.111425 |
| _version_ | 1785062910596218880 |
|---|---|
| author | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_facet | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_sort | Kow, Chia Siang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10292911 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102929112023-06-27 Famotidine: A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad J Psychosom Res Letter to the Editor Elsevier Inc. 2023-06-26 /pmc/articles/PMC10292911/ /pubmed/37399740 http://dx.doi.org/10.1016/j.jpsychores.2023.111425 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad Famotidine: A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment |
| title | Famotidine: A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment |
| title_full | Famotidine: A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment |
| title_fullStr | Famotidine: A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment |
| title_full_unstemmed | Famotidine: A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment |
| title_short | Famotidine: A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment |
| title_sort | famotidine: a potential mitigator of mast cell activation in post-covid-19 cognitive impairment |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292911/ https://www.ncbi.nlm.nih.gov/pubmed/37399740 http://dx.doi.org/10.1016/j.jpsychores.2023.111425 |
| work_keys_str_mv | AT kowchiasiang famotidineapotentialmitigatorofmastcellactivationinpostcovid19cognitiveimpairment AT ramachandramdineshsangarran famotidineapotentialmitigatorofmastcellactivationinpostcovid19cognitiveimpairment AT hasansyedshahzad famotidineapotentialmitigatorofmastcellactivationinpostcovid19cognitiveimpairment |